Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOCILIZUMAB Cause Liver function test abnormal? 526 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 526 reports of Liver function test abnormal have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.5% of all adverse event reports for TOCILIZUMAB.

526
Reports of Liver function test abnormal with TOCILIZUMAB
0.5%
of all TOCILIZUMAB reports
5
Deaths
105
Hospitalizations

How Dangerous Is Liver function test abnormal From TOCILIZUMAB?

Of the 526 reports, 5 (1.0%) resulted in death, 105 (20.0%) required hospitalization, and 77 (14.6%) were considered life-threatening.

Is Liver function test abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 526 reports have been filed with the FAERS database.

What Other Side Effects Does TOCILIZUMAB Cause?

Drug ineffective (32,342) Rheumatoid arthritis (20,652) Pain (18,384) Off label use (18,256) Arthralgia (15,536) Joint swelling (14,831) Fatigue (13,802) Rash (12,327) Drug intolerance (11,952) Contraindicated product administered (11,547)

What Other Drugs Cause Liver function test abnormal?

METHOTREXATE (1,416) ETANERCEPT (1,013) ADALIMUMAB (879) INFLIXIMAB (609) ATORVASTATIN (579) LEFLUNOMIDE (489) ACETAMINOPHEN (465) TOFACITINIB (436) ABATACEPT (431) HYDROXYCHLOROQUINE (429)

Which TOCILIZUMAB Alternatives Have Lower Liver function test abnormal Risk?

TOCILIZUMAB vs TOCILIZUMAB-AAZG TOCILIZUMAB vs TOCOPHEROL TOCILIZUMAB vs TOFACITINIB TOCILIZUMAB vs TOFERSEN TOCILIZUMAB vs TOLNAFTATE

Related Pages

TOCILIZUMAB Full Profile All Liver function test abnormal Reports All Drugs Causing Liver function test abnormal TOCILIZUMAB Demographics